The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, after losing nearly five stone, discontinued Mounjaro due to hair loss ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound ...

Janelle Rohner/Instagram Health and wellness influencer Janelle Rohner is receiving backlash after revealing that she’s been taking medication for weight loss. The 37-year-old, who has 5.2 ...

medical therapies and surgical options offer powerful tools to support lasting change. Ultimately, the key to lasting weight loss and improved health lies in understanding that there is no one ...

As Ozempic and other GLP-1 medications continue to grow in popularity for weight loss, a concoction dubbed "oatzempic" is trending. The blended beverage, which consists of oats, lime juice ...

When considering the top stocks, funds and trusts to invest in, are the pharmaceutical and biotech companies behind weight-loss drugs worth a look? “In 2021, Lisa Chen, a software engineer ...

Rewarding weight loss with food can undo progress and reinforce ... purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions ...

Getty A woman is confused after her friend called her out at a house party for not complimenting her on her weight loss journey. Wondering if she’s in the wrong, the woman detailed what led to ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. Its off-label use, fueled by celebrity ...